Develops RNA-based therapeutics using innovative manufacturing and synthesis platform to advance mRNA treatments and formulations.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Nutcracker Therapeutics is a biotechnology company focused on advancing RNA-based treatments through innovative manufacturing technologies. Nutcracker aims to revolutionize the development of RNA therapeutics by leveraging its proprietary platform for mRNA synthesis and formulation.
Nutcracker Therapeutics Funding
Sign up to gain insights into Nutcracker Therapeutics funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series C | Aug 27, 2021 | 144M | ||
| Series B | May 08, 2020 | 14M | ||
| Series A | Mar 11, 2019 | 10M | ||
| Series Seed | Apr 30, 2018 | 4M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Nutcracker Therapeutics Management Team
Investors
ARCH Venture Partners
Bluebird Ventures
Sutter Hill Ventures
Nutcracker Therapeutics Valuations & Financials
View real-time NPM data on Nutcracker Therapeutics stock including daily Nutcracker Therapeutics stock price estimates, valuation history, and historical share price information. Access Nutcracker Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Nutcracker Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Nutcracker Therapeutics? Get in touch to learn more.
Similar Companies
like Nutcracker Therapeutics
Droplet Biosciences
Healthcare & Life Sciences
Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.
Lyra
Healthcare & Life Sciences
Digital health startup using technology to connect companies and employees to mental health providers.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Curology
Healthcare & Life Sciences
Offers personalized prescription skin care medications delivered directly to you.
Carrot Fertility
Healthcare & Life Sciences
Medical services including egg freezing and in vitro fertilization (IVF).
Attovia
Healthcare & Life Sciences
Pipeline of bio-therapeutics with an initial focus on immune-mediated diseases.
Scribe
Healthcare & Life Sciences
Focused on the development of CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.
FAQ
We have answers
Nutcracker Therapeutics stock does not trade on public stock exchanges. Nutcracker Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Nutcracker Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Nutcracker Therapeutics Stock does not trade on public stock exchanges. In order to sell Nutcracker Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nutcracker Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Nutcracker Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Nutcracker Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Nutcracker Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Nutcracker Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Nutcracker Therapeutics is a private company and has not had an IPO. There is currently no Nutcracker Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Nutcracker Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
